Tag: psychopharmacology

Daniel Lee, MD: Challenge Assumptions, Follow the Evidence, Advance the Science

I’m pleased to share my professional biography, reflecting a career that has taken me from military medicine and psychiatry to the FDA, global pharmaceutical clinical development, scientific research, and independent consulting. Throughout that journey, I have remained committed to rigorous science, transparent and ethical leadership, and advancing innovative treatments that can make a meaningful difference for patients, particularly across CNS and psychiatric conditions. As I continue exploring opportunities to contribute at the board and advisory level, I look forward to bringing these experiences to organizations navigating complex scientific, clinical, regulatory, and strategic challenges.

Dr. Kashinath Yadalam: Pioneering Psychiatrist and Clinical Trials Leader

Dr. Kashinath Yadalam is a seasoned psychiatrist and clinical research leader with over 40 years of experience advancing treatments for psychiatric and neurological disorders. As Owner and Medical Director of Lake Charles Clinical Trials, he has built a respected institution known for its high standards in ethical, safe, and innovative clinical research. A Distinguished Life Fellow of the American Psychiatric Association and a Certified Physician Investigator, Dr. Yadalam has collaborated with pharmaceutical companies, academic institutions, and regulatory bodies to design and oversee groundbreaking trials in psychopharmacology. His career reflects a lifelong commitment to improving mental health care through scientific rigor, compassionate practice, and academic excellence.